Insider sales of Pulmonx shares below the current price, including by Glendon French, could indicate comfort with a lower valuation. A lack of insider purchases in the past year and low insider ownership might suggest a lack of alignment between management and small shareholders.
Pulmonx股票讨论
pulmonx宣布在2024年欧洲呼吸学会大会上展示了AeriSeal® CONVERt试验的临床数据和LIBERATE研究的5年后随访数据
pulmonx(纳斯达克:LUNG)在2024年欧洲呼吸学会大会上展示了两项重要研究的临床数据。AeriSeal® CONVERt试验显示,在使用AeriSeal系统治疗后,77.6%具有并发通气(CV+)的患者成功转为CV-状态...
暂无评论